Immunosuppression in the Tumor Microenvironment Mediated by Metabolites Derived from the Gut Microbiota
Oncology Advances · 2023
DOI: 10.14218/ona.2023.00014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Advances, 2023. Verfasst von Anastasia A. Zabolotneva und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tumors interact with various populations of nonmalignant cells, such as endothelial, stromal, and immune cells, to create a favorable tumor microenvironment (TME) for invasion and metastasis of cancer cells. A key mechanism for maintaining the pro-oncogenic properties of the TME is the formation of an immunosuppressive environment that allows the tumor to avoid an immune response. A strictly immunosuppressive environment is supported mainly by the activity of engaged immune cells that secrete inflammatory cytokines and factors that inhibit the function of cytotoxic T lymphocytes. On the other hand, the activity of tumor-associated immune cells depends not only on cancer-cell signals but also on microbial metabolites derived from the gut microbiota. The gut microbiota consists of bacteria, viruses, protozoans, archaea, and fungi that influence the host immune response, DNA damage, and chronic inflammation in gastrointestinal and other cancers, such as breast cancer. In particular, intestinal dysbiosis can lead to restructuring of the TME and the promotion of tumor growth. Recently, a wide spectrum of bacterial metabolites, such as short-chain fatty acids, tryptophan catabolites, secondary bile acids, etc., have been shown to have a signaling function that affects not only the formation of the TME but also the response of cancer cells to therapeutic agents, including immunotherapy. Therefore, studying the effects of microbiota metabolites in relation to cancer development and cancer therapy effectiveness is strictly necessary. In this review, we briefly describe key microbiota factors that influence the formation of immunosuppressive TMEs.
Zitieren
APA
Zabolotneva, A. A., Shatova, O. P., Shegai, P. V., & Shestopalov, A. V. (2023). Immunosuppression in the Tumor Microenvironment Mediated by Metabolites Derived from the Gut Microbiota. Oncology Advances. https://doi.org/10.14218/ona.2023.00014
Vancouver
Zabolotneva AA, Shatova OP, Shegai PV, Shestopalov AV. Immunosuppression in the Tumor Microenvironment Mediated by Metabolites Derived from the Gut Microbiota. Oncology Advances. 2023. doi:10.14218/ona.2023.00014
BibTeX
@article{Zabolotneva2023,
author = {Zabolotneva, Anastasia A. and Shatova, Olga P. and Shegai, Peter V. and Shestopalov, Aleksandr V.},
title = {Immunosuppression in the Tumor Microenvironment Mediated by Metabolites Derived from the Gut Microbiota},
journal = {Oncology Advances},
year = {2023},
doi = {10.14218/ona.2023.00014}
}
EUVIMED